{"id":601517,"title":"Australia Canada Singapore Switzerland (ACSS) Consortium – Erleada approval - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-10","captureTimestamp":"2026-03-10T14:54:56.772000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/corporate/transparency/regulatory-transparency-and-openness/improving-review-drugs-devices/notice-erleada.html","snippet":"Australia Canada Singapore Switzerland (ACSS) Consortium – Erleada approval July 13, 2018 Our file number: 18-108470-709 On July 4, 2018 Health Canada approved the first drug to be evaluated under the Australia-Canada-Singapore-Switzerland (ACSS) Consortium’s New Chemical…","rawSnapshotUrl":"/api/snapshots/raw/601517","browseUrl":"https://replay.healtharchive.ca/job-6/20260310145456/https://www.canada.ca/en/health-canada/corporate/transparency/regulatory-transparency-and-openness/improving-review-drugs-devices/notice-erleada.html#ha_snapshot=601517","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}